As of 2025-11-29, the Relative Valuation of Antares Pharma Inc (ATRS) is 6.83 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.59 USD, the upside of Antares Pharma Inc based on Relative Valuation is 22.2%.
The range of the Relative Valuation is 6.16 - 8.24 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 18.5x - 24.7x | 20.5x |
| Fair Price | 6.16 - 8.24 | 6.83 |
| Upside | 10.2% - 47.4% | 22.2% |
| Date | P/E |